학술논문
End of dose interval symptoms in patients treated with natalizumab: A role for serum cytokines?
Document Type
Article
Author
Source
In: Multiple Sclerosis and Related Disorders . (Multiple Sclerosis and Related Disorders, June 2020, 41)
Subject
Language
English
ISSN
22110356
22110348
22110348